←
Replicate Bioscience, Inc.71 posts
Replicate Bioscience, Inc. avatar

Replicate Bioscience, Inc.

@Replicate_Bio

The Power of RNA Amplified Pioneering novel self-replicating RNA (srRNA) technology for widespread use.

◷ Joined June 2020▧ 43 Photos and videos
Replicate Bioscience, Inc. avatar
Replicate Bioscience, Inc.@Replicate_Bio·Mar 26

What makes srRNA different? Once inside your cells, it doesn’t just deliver an instruction, it delivers the machinery to keep copying it. Thank you to @cure345 for spotlighting Replicate among the companies shaping the future of mRNA vaccines. wewillcure.com/insights/comp…

Replicate Bioscience, Inc. avatar
Replicate Bioscience, Inc.@Replicate_Bio·24 Sep 2025

Today we announced the publication of our Phase 1 trial for RBI-4000, our #srRNA rabies vaccine, in @CommsMedicine. Results show durability 6x greater than standard vaccines - a first for #RNA. Learn more: nature.com/articles/s43856-0…

Replicate Bioscience, Inc. avatar
Replicate Bioscience, Inc.@Replicate_Bio·8 Sep 2025

We’re kicking off September at #RNALeaders USA Congress – where CEO Nathaniel Wang will speak to the advantages of srRNA, including durability. We look forward to discussing Replicate’s latest progress, as well as the advantages of srRNA - we hope to see you there!

Post attachment
Replicate Bioscience, Inc. avatar
Replicate Bioscience, Inc.@Replicate_Bio·28 Aug 2025

Big news today: Replicate enters a $550M+ exclusive deal with @novonordisk Together, we’ll advance our self-replicating RNA (srRNA) technology for obesity, type 2 diabetes, and cardiometabolic disease. A milestone moment for RNA therapeutics. Read more: replicatebioscience.com/repl…

Replicate Bioscience, Inc. avatar
Replicate Bioscience, Inc.@Replicate_Bio·7 Feb 2025

Today we announced a paper in @NatureComms highlighting our Phase I clinical study of RBI-4000 an #srRNA rabies #vaccine. Results suggest RBI-4000 could offer much needed treatment option for #rabies. Congratulations to all who contributed to this work! nature.com/articles/s41467-0…

Replicate Bioscience, Inc. avatar
Replicate Bioscience, Inc.@Replicate_Bio·8 Nov 2024

Mark your calendar: Next week, our Head of Research & Development, Parinaz (Paris) Aliahmad, will present clinical data demonstrating the expanded therapeutic index of a novel #srRNA #vaccine at the 12th International #mRNA Health Conference. We hope to see you there!

Post attachment
Replicate Bioscience, Inc. avatar
Replicate Bioscience, Inc.@Replicate_Bio·10 Oct 2024

Next week, Replicate will attend the DCVMN International 25th Annual General Meeting. We look forward to insightful discussions on prioritizing accessibility in #vaccine development, manufacturing, and roll out to ensure that scientific advancements benefit all populations. #RNA

Post attachment